期刊文献+

猪β防御素-1基因乳腺特异性表达载体的构建 被引量:2

Construction of marker removable,mammary specific porcine β-defensin 1 expression vector
下载PDF
导出
摘要 为构建标记基因可去除的β防御素-1(pBD-1)基因乳腺特异性表达载体,利用RT-PCR方法从猪脾脏中克隆获得pBD-1基因,再插入乳腺特异性表达骨架载体pBC1-neo中;经PCR、酶切电泳以及测序鉴定,确认成功构建出乳腺特异性表达pBD-1的载体。进一步将上述功能片段亚克隆至能将标记基因全部去除的骨架载体MCS-3s-loxP-GFP中,成功构建了一种筛选标记可全部去除的乳腺特异性3s-loxP-GFP-pBC1-pBD1转基因载体。该载体为研究pBD-1蛋白的抗菌活性、抗菌机制,以及创制乳腺高效表达pBD-1的转基因猪育种新材料和通过哺乳以提高新生仔猪抗病力奠定了基础。 Porcine β-defensin 1 (pBD-1) is a cationic peptide, widely spread in porcine organs, and plays an important role in porcine disease defence. In order to construct maker removable and mammary gland specific pBD-l expression vec- tor, the present study firstly performed RT-PCR to obtain coding sequence of pBD-1 gene from porcine spleen, and sub- sequently inserted the pBD-1 fragment into pBCl-neo. PCR, enzymatic digestion and seqencing results confirmed that the mammary gland specific pBD-1 vector was successfully constructed. Then, the combined fragment (including 5~ and 3' regulating region of β-casein and pBD-1) was moved into MCS-3s-loxP-GFP, and the marker removable and mammary gland specific expression vector 3s-loxP-GFP-pBCI-pBD1 was constructed. These results may pave the way to study anti- microbia activities and its mechanism of the pBD-1, and also are helpful to make marker-free transgenic porcine mammary bioreactors producing pBD-1, which would improve the immuno function of defensing against pathogenic bacteria, thereby increase the new born natural disease resistance.
出处 《扬州大学学报(农业与生命科学版)》 CAS CSCD 北大核心 2013年第1期1-6,共6页 Journal of Yangzhou University:Agricultural and Life Science Edition
基金 国家转基因生物新品种培育科技重大专项(2009ZX08006-004B)
关键词 β防御素-1 标记去除 抗病育种 乳腺生物反应器 转基因动物 pig β-defensin 1 marker-free breeding for disease resistance mammary gland bioreaetor transgenicanimal
  • 相关文献

参考文献25

  • 1Rosenberger C M, Gallo R L, Finlay B B. Interplay between antibacterial effectors: a macrophage antimicrobialpeptide impairs intracellular Salmonella replication [J]. Proc Natl Acad Sci USA, 2000,101(8) : 2422-2427.
  • 2Diamond G,Zasloff M, Eck H, et al. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tra-cheal mucosa: peptide isolation and cloning of a cDNA [J]. Proc Natl Acad Sci USA, 1991, 88(9) . 3952-3956.
  • 3Zhang G,Hiraiwa H,Yasue H,et al. Cloning and characterization of the gene for a new epithelial beta-defensin:genomic structure, chromosomal localization, and evidence for its constitutive expression [J]. J Biol Chem, 1999,274(34): 24031-24037.
  • 4Zhang G,Wu H, Shi J, et al. Molecular cloning and tissue expression of porcine beta-defensin-1 [J]. FEBS Lett,1998,424(1/2) : 37-40.
  • 5Shi J, Zhang G,Wu H,et al. Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobialconcentrations [J], Infect Immun,1999,67(6) : 3121-3127.
  • 6Sang Y,Ramanathan B, Ross C R,et al. Gene silencing and overexpression of porcine peptidoglycan recognitionprotein long isoforms: involvement in beta-defensin- 1 expression [J]. Infect Immun, 2005,73(11) : 7133-7141.
  • 7Elahi S,Brownlie R,Korzeniowski J,et al. Infection of newborn piglets with Bordetella pertussis: a new modelfor pertussis [J]. Infect Immun,2005,73(6) : 3636-3645.
  • 8Kerr D E, Plaut K, Bramley A J, et al. Lysostaphin expression in mammary glands confers protection againststaphylococcal infection in transgenic mice [J]. Nat Biotechnol,2001, 19(1): 66-70.
  • 9Yarus S, Rosen J M, Cole A M, et al. Production of active bovine tracheal antimicrobial peptide in milk of trans-genic mice [J]. Proc Natl Acad Sci USA, 1996, 93(24) : 14118-14121.
  • 10Maga E A, Anderson G B, Huang M C,et al. Expression of human lysozyme mRNA in the mammary gland oftransgenic mice [J]. Transgenic Res, 1994,3(1) : 36-42.

同被引文献25

  • 1Lee K, Shin S Y, Kim K, et al. Antibiotic activity and structural analysis of the scorpion-derived antimicrobial pep- tide IsCT and its analogs [J], Biochem Biophys Res Commun, 2004, 323(2): 712-719.
  • 2Harder J, Bartels J, Christophers E, et al. Isolation and characterization of human p-defensin-3, a novel human in- ducible peptideantibiotics[J]. BiolChem, 2001, 276(8): 5707-5713.
  • 3Feng Z M Dubyak R G, Michael M. Cutting edge= human fl-defensin-3: a novel antagonist of the HIV-1 coreceptor CXCR4 [J]. Immunol, 2006, 177(2): 782-786.
  • 4l:underburg N, l.ederman M M, Feng Z M. Human/}defensin-3 activates p Toll-like receptors and 2 [J]. PNAS, 2007, 104(47): 18631-18635.
  • 5Yasin B, Pang M, Turner J S, et al. Evaluation of the inaclivation of infect lense peptides [J] Eur J Clin Microbiol Infect Dis, 2000, 19(3) : 187-194.
  • 6Wang Y Q, Agerberth B, Lothgren A, et al. Apolipoprotein A-I binds and toxic peptide I.I:37[J]. BiolChem, 1998, 273(50): 33115-33118.
  • 7Corrales-Gareia I., Ortlz E, Castaneda-Delgado J, et al. Bacterial expression and ants of human/9-defensins on pathogenic bacteria and M. tuberculosis [J]. ProteinExpr Purif, 2013, 89(1): 33-43.
  • 8Huang L, Xu Z, Zhong Z, et al. Enhanced expression and primary purification of soluble HBD3 fusion protein in Escherichia coli [J]. Appl Biochem Biotechnol, 2007, 142(2): 139-147.
  • 9Huang L, Wang J, Zhong Z, et al. Production of bioactive human beta-defensin-3 in Escherichia coli by soluble fusion expression [J]. Biotechnol Letters, 2006, 28(9): 627-632.
  • 10Ge X, Yang D S, Trabbic-Carlson K, et al. Self-cleavable stimulus responsive tags for protein purification without chromatography [J]. J Am Chem Soc, 2005, 27(32) : 11228-11229.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部